Summary
These insightful reports provide:
Complete assessment of the leading emerging economies at a time of financial upheaval and challenge
Regularly updated 5-year forecasts and market valuations for each market
Detailed analysis of the health structure, funding, service and outlook for each market
Critical SWOT and assessment of the market
Published quarterly to provide the latest information
Description
Many are concerned that the global economic downturn is blunting the rapid growth in the BRIC countries. Is this a time of exciting opportunity or commercial danger for medical manufacturers and how is the economic turmoil affecting each market? These reports separate fact from fiction and are essential in making sound, impartial business judgements.
These insightful reports provide:
Complete assessment of the leading emerging economies at a time of financial upheaval and challenge
Regularly updated 5-year forecasts and market valuations for each market
Detailed analysis of the health structure, funding, service and outlook for each market
Critical SWOT and assessment of the market
Published quarterly to provide the latest information
These leading emerging economies represent a total medical market of US$20.9 billion. But how might the impact of the economic downturn affect them? Where do commercial opportunities exist for medical device companies now, and what are the future prospects?
Putting things in perspective
With a combined population of 2.7 billion people and with significant unmet medical need, the challenges and opportunities of the BRIC markets are considerable. The economic downturn has affected these markets varyingly; for example, the Brazilian import market may be affected by disadvantageous US$ exchange rates, but China is affected more by a weak economy in the USA, its major market. Significant growth rates, up to 9.1% in China for example, are impressive, but the low starting point - along with a range of other operational issues - means companies must be targeted in the opportunities they pursue.
Opportunities do exist
There are, of course, wide regional differences in expenditure levels within the BRIC countries, far more so than in developed countries where health systems have evolved to provide a more uniform level of coverage. All four countries have a relatively wealthy urban population with a far greater spending power than their respective national average. These urban populations have grown rapidly, and number hundreds of millions. The challenge for these countries is to extend this level of wealth to the rest of the population, in order that better levels of healthcare become affordable.
A long haul
The prevailing economic woes have to be seen over the long term. This is evolution not revolution, and change will be incremental. Short-term opportunities exist in meeting the health demands of the burgeoning middle classes, and future prospects are bright, where steady growth in BRIC markets will erode commercial differences with the established markets in North America, Japan and Europe.
Current and accurate decision support information is vital
Effective planning is vital and that is why Espicom, the leading provider of medical market intelligence, has issued this report collection The Outlook for Medical Devices in Brazil, Russia, India & China to 2016. For each country there is a comprehensive examination of the market for medical devices and equipment which covers all aspects of the operating environment from the regulatory situation through health provision/expenditure to domestic production. Importantly, each market evaluation includes 5 year growth forecasts and SWOT analysis. An additional benefit - and at no additional cost - is that these reports are updated and issued quarterly and include an annually updated statistical report packed with hard-to-source health market facts and figures.
SNAPSHOTS FROM THE REPORTS....
BRAZIL Brazil has the largest medical device market in the Latin American region. In 2011, the Brazilian medical market is valued at US$4.0 billion equivalent to around US$21 per capita. Expenditure is far higher in developed urban areas, however. The country has a well established medical industry, comprising local and multinational companies. Imports had been fuelled by the appreciation of local currency against the dollar and increasing consumer demand for the latest technology. However, a more realistic exchange rate contained medical imports in 2009. Imports tend to be high-tech medical equipment not produced locally. In 2009, 68% of imports were supplied by Europe and the USA. More opportunities exist in the private sector.
RUSSIA In 2011, the Russian market for medical equipment and supplies is estimated at US$6.0 million. This puts the market among the top 20 in the world, although per capita spending remains low, at around US$42. Around 75% of the market is supplied by imports. Germany, the USA and Japan were the leading suppliers in 2009, accounting for over 50% of imports. The value of imports greatly increased up to 2008, but was hit hard by the recession in 2009. The market, however, remains strongly reliant on products from abroad, as domestic producers are small and under-capitalised.
INDIA The Indian market for medical equipment is valued at around US$2.6 billion in 2011. Despite strong growth rates, the market remains disproportionately small, ranking among the top 20 in the world but with low per capita spending. High quality products are sought after, particularly in the private sector, and the high-tech end of the medical device market is dominated by multinationals with extensive service networks. Indian manufacturers of good quality mid-tech products struggle with a stigma for unreliability. Indian purchasers are, however, price-sensitive and seek value for money. Continued investment in the private sector infrastructure, coupled with increased healthcare funding from the government, should result in a steady increase in the market for medical equipment.
CHINA For 2011, Espicom estimates market growth to be in the region of 13.1%, one of the fastest growing markets in the world. High rates of growth are not uncommon in the Asian region, but on the back of a huge market size, China's growth is particularly pronounced. In 2011, the country's market valuation, at US$8.6 billion, makes it one of the largest in the world. The Chinese medical device market is largely supplied by imports or products made locally by multinational joint ventures especially at the higher end of the technology scale. The Chinese market represents many opportunities for foreign business, and if new regulatory reforms prove successful and the inadequacy of rural healthcare is effectively addressed, then the sheer number of previously untapped consumers makes China an attractive proposition.
More Information...
KEY MEDICAL INDUSTRY STATISTICS
BRAZIL: Medical Market Size
US$3.6 billion
As a % of health expenditure
2.2%
Growth
6.1%
Per capita spend
US$18
RUSSIA: Medical Market Size
US$5.96 billion
As a % of health expenditure
6.4%
Growth
15.3%
Per capita spend
US$42
INDIA: Medical Market Size
US$2.7 billion
As a % of health
expenditure
3.7%
Growth
15.6%
Per capita spend
US$2
CHINA: Medical Market Size
US$8.6 billion
As a % of health expenditure
2.6%
Growth
13.6%
Per capita spend
US$6
Track economic and market performance with these reports
MEDICAL MARKET ANALYSIS
Size
Projections & Outlook - Unique 5-year Market Projections by Major Product/Technology, SWOT Analysis, Comment & Rating
Imports
Domestic Manufacturing
Domestic Production - Trade Association(s), Local/Multinational Manufacturers
Exports
ACCESSING THE MARKET
Distribution - including qualified sales agency and distribution leads worldwide
Medical Device Regulations
HEALTHCARE ANALYSIS
Demographics - Population, Birth Rate, Death Rate, Infant Mortality, Life Expectancy at Birth,
Public Health - Causes of Death, Incidence of Communicable Diseases,
Healthcare System
Health Expenditure - Health Estimates for 2009, Projected Health Expenditure
Healthcare Infrastructure
Healthcare Personnel
DIRECTORY
Healthcare Organisations
Professional Bodies/Trade Associations
Trade Code Classifications Methodology & Sources
EXTENSIVE STATISTICAL TABLES
Thousands of key statistics and trends are provided in an appendix. Data is included from several years allowing trends to be identified and new changes to be seen in historical
context. The statistics cover key indicators such as:
Population Trends
Principal Causes of Death
Public Health Expenditure
Hospital Data: Beds by Type, Discharge Data and Average
Length of Stay Patients by Type
Healthcare Personnel: Numbers of Doctors, Nurses etc by Type
Espicom's Customised Market Service: Did you know that all of Espicom's extensive range of market, company and therapy services can be selected to create a web-based information solution which meets your needs precisely.
